During the Pandemic, Telemedicine Follow-up for Heart Failure Improved 30-Day Outcomes
A study examined if early outpatient follow-up via telemedicine reduces 30-day readmission in patients with heart failure as effectively as in-person follow-up.
A study examined if early outpatient follow-up via telemedicine reduces 30-day readmission in patients with heart failure as effectively as in-person follow-up.
The VALOR-HCM trial evaluated the effects of mavacamten in over 100 patients with symptomatic obstructive HCM (NYHA class III-IV) who met the guideline criteria for SRT and had been referred for an invasive procedure.
Researchers examined the association between pre-existing heart failure and cancer incidence and mortality in a community-based cohort.
The NDA is supported by data from the phase 3 GALACTIC-HF trial which included 8256 adults with heart failure with reduced ejection fraction,
Affordability of SGLT2i may contribute to the low prescription rate in CKD.
The designation was based on data from the phase 2 REDWOOD-HCM trial.
The application is supported by data from the phase 3 EMPEROR-Preserved trial.
Researchers examined the effect of implantable cardiac assistive devices on patients’ quality of life.
The new packaging allows for ease of administration and convenience.
This study sought to characterize sex differences in heart failure physical frailty phenotypes.